Outcome after Treosulfan-based conditioning in a real-world MDS cohort.

Bone Marrow Transplant · 2025 · PMC12583125 · PMID 40926034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast, unrelated donor transplant ( p = 0.07, HR 0.48 [0.22–1.1]) and in-vivo T-cell depletion ( p = 0.06, HR 0.47 [0.2–1.04]) showed a trend towards improved RFS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.